Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method

Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vi...

Full description

Bibliographic Details
Main Authors: Shu Miao, Chenxi Guo, Ze Jiang, Hao-Xiang Wei, Xin Jiang, Jingkai Gu, Zhuo Hai, Tianren Wang, Yun-Hui Liu
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/12/9/766
_version_ 1797490535079870464
author Shu Miao
Chenxi Guo
Ze Jiang
Hao-Xiang Wei
Xin Jiang
Jingkai Gu
Zhuo Hai
Tianren Wang
Yun-Hui Liu
author_facet Shu Miao
Chenxi Guo
Ze Jiang
Hao-Xiang Wei
Xin Jiang
Jingkai Gu
Zhuo Hai
Tianren Wang
Yun-Hui Liu
author_sort Shu Miao
collection DOAJ
description Oocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vitrification and is currently the most commonly used method in reproductive centers. However, the Cryotop method requires precise and complex manual manipulation by an embryologist, whose proficiency directly determines the effect of vitrification. Therefore, in this study, an automatic microfluidic system consisting of a novel open microfluidic chip and a set of automatic devices was established as a standardized operating protocol to facilitate the conventional manual Cryotop method and minimize the osmotic shock applied to the oocyte. The proposed open microfluidic system could smoothly change the CPA concentration around the oocyte during vitrification pretreatment, and transferred the treated oocyte to the Cryotop with a tiny droplet. The system better conformed to the operating habits of embryologists, whereas the integration of commercialized Cryotop facilitates the subsequent freezing and thawing processes. With standardized operating procedures, our system provides consistent treatment effects for each operation, leading to comparable survival rate, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) level of oocytes to the manual Cryotop operations. The vitrification platform is the first reported microfluidic system integrating the function of cells transfer from the processing chip, which avoids the risk of cell loss or damage in a manual operation and ensures the sufficient cooling rate during liquid nitrogen (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><msub><mi>LN</mi><mn>2</mn></msub></semantics></math></inline-formula>) freezing. Our study demonstrates significant potential of the automatic microfluidic approach to serve as a facile and universal solution for the vitrification of various precious cells.
first_indexed 2024-03-10T00:34:21Z
format Article
id doaj.art-544d387632bb4e1ea8219b78e0a8ed73
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-10T00:34:21Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-544d387632bb4e1ea8219b78e0a8ed732023-11-23T15:18:47ZengMDPI AGBiosensors2079-63742022-09-0112976610.3390/bios12090766Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop MethodShu Miao0Chenxi Guo1Ze Jiang2Hao-Xiang Wei3Xin Jiang4Jingkai Gu5Zhuo Hai6Tianren Wang7Yun-Hui Liu8School of Mechanical Engineering and Automation, Harbin Institute of Technology, Shenzhen 518055, ChinaShenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518005, ChinaThe T Stone Robotics Institute, Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Hong Kong SAR, ChinaThe T Stone Robotics Institute, Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Hong Kong SAR, ChinaSchool of Mechanical Engineering and Automation, Harbin Institute of Technology, Shenzhen 518055, ChinaShenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518005, ChinaShenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518005, ChinaShenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen 518005, ChinaThe T Stone Robotics Institute, Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, Hong Kong SAR, ChinaOocyte vitrification technology is widely used for assisted reproduction and fertility preservation, which requires precise washing sequences and timings of cryoprotectant agents (CPAs) treatment to relieve the osmotic shock to cells. The gold standard Cryotop method is extensively used in oocyte vitrification and is currently the most commonly used method in reproductive centers. However, the Cryotop method requires precise and complex manual manipulation by an embryologist, whose proficiency directly determines the effect of vitrification. Therefore, in this study, an automatic microfluidic system consisting of a novel open microfluidic chip and a set of automatic devices was established as a standardized operating protocol to facilitate the conventional manual Cryotop method and minimize the osmotic shock applied to the oocyte. The proposed open microfluidic system could smoothly change the CPA concentration around the oocyte during vitrification pretreatment, and transferred the treated oocyte to the Cryotop with a tiny droplet. The system better conformed to the operating habits of embryologists, whereas the integration of commercialized Cryotop facilitates the subsequent freezing and thawing processes. With standardized operating procedures, our system provides consistent treatment effects for each operation, leading to comparable survival rate, mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) level of oocytes to the manual Cryotop operations. The vitrification platform is the first reported microfluidic system integrating the function of cells transfer from the processing chip, which avoids the risk of cell loss or damage in a manual operation and ensures the sufficient cooling rate during liquid nitrogen (<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><msub><mi>LN</mi><mn>2</mn></msub></semantics></math></inline-formula>) freezing. Our study demonstrates significant potential of the automatic microfluidic approach to serve as a facile and universal solution for the vitrification of various precious cells.https://www.mdpi.com/2079-6374/12/9/766open microfluidic chipcell manipulationvitrification
spellingShingle Shu Miao
Chenxi Guo
Ze Jiang
Hao-Xiang Wei
Xin Jiang
Jingkai Gu
Zhuo Hai
Tianren Wang
Yun-Hui Liu
Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
Biosensors
open microfluidic chip
cell manipulation
vitrification
title Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_full Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_fullStr Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_full_unstemmed Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_short Development of an Open Microfluidic Platform for Oocyte One-Stop Vitrification with Cryotop Method
title_sort development of an open microfluidic platform for oocyte one stop vitrification with cryotop method
topic open microfluidic chip
cell manipulation
vitrification
url https://www.mdpi.com/2079-6374/12/9/766
work_keys_str_mv AT shumiao developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT chenxiguo developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT zejiang developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT haoxiangwei developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT xinjiang developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT jingkaigu developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT zhuohai developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT tianrenwang developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod
AT yunhuiliu developmentofanopenmicrofluidicplatformforoocyteonestopvitrificationwithcryotopmethod